SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

PLoS One. 2013;8(12):e80525.

The association of maximum body weight on the development of type 2 diabetes and microvascular complications: MAXWEL study.

, , , , , , , ,

제1저자 임수 · 교신저자 장학철

소속 (1)
  1. Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seongnam, Korea ; Division of General Medicine, Harvard Medical School, Boston, Massachusetts, United States of America ; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.

Abstract

BACKGROUND Obesity precedes the development of type 2 diabetes (T2D). However, the relationship between the magnitude and rate of weight gain to T2D development and complications, especially in non-White populations, has received less attention.

METHODS AND FINDINGS We determined the association of rate and magnitude of weight gain to age at T2D diagnosis (Age(T2D)), HbA1c at T2D diagnosis (HbA1c(T2D)), microalbuminuria, and diabetic retinopathy after adjusting for sex, BMI at age 20 years, lifestyles, family history of T2D and/or blood pressure and lipids in 2164 Korean subjects aged ≥30 years and newly diagnosed with diabetes. Body weight at age 20 years (Wt(20y)) was obtained by recall or from participants' medical, school, or military records. Participants recalled their maximum weight (Wt(max)) prior to T2D diagnosis and age at maximum weight (Age(max_wt)). The rate of weight gain (Rate(max_wt)) was calculated from magnitude of weight gain (ΔWt = Wt(max)-Wt(20y)) divided by ΔTime (Age(max_wt) -20 years). The mean Age(max_wt) and Age(T2D) were 41.5±10.9 years and 50.1±10.5 years, respectively. The Wt(20y) and Wt(max) were 59.9±10.5 kg and 72.9±11.4 kg, respectively. The Rate(max_wt) was 0.56±0.50 kg/year. After adjusting for risk factors, greater ΔWt and higher Rate(max_wt) were significantly associated with earlier Age(T2D), higher HbA1c(T2D) after additional adjusting for Age(T2D), and microalbuminuria after further adjusting for HbA1c(T2D) and lipid profiles. Greater ΔWt and higher Rate(max_wt) were also significantly associated with diabetic retinopathy.

CONCLUSIONS This finding supports public health recommendations to reduce the risk of T2D and its complications by preventing weight gain from early adulthood.

Figures

Figure 1
Figure 1 Definitions of weight-related variables and study design.
Figure 2
Figure 2 Three-dimensional graphs showing the association among three factors: AgeT2D (age at diagnosis of type 2 diabetes), ΔWt (maximum weight in lifetime – weight at age 20 years), and ΔTime (age at maximum weight –20 years).
Figure 3
Figure 3 Comparison of age at T2D diagnosis, HbA1c at T2D diagnosis, microalbuminuria, and diabetic retinopathy between rapid and slow weight gainers defined as the highest and lowest quartiles of Ratemax_wt. Mean values with 25–75% ranges in box and 5–95% ranges in outer lines are displayed in Box and Whisker plots. Outliers who do not belong to the 5–95% ranges are displayed as dots. Log-transformed urine albumin-to-creatinine ratio was used for microalbuminuria. *indicates P<0.01.

그림 출처: PubMed Central 공개 논문 (PMC3851456)

Conflict of interest statement

Competing Interests:The authors have declared that no competing interests exist.

그 밖의 정보
출판 형태
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
저널
PloS one · eISSN 1932-6203
전자 출판
2013-12-04
MeSH
Adult · Aged · Albuminuria / blood / complications / ethnology / physiopathology · Asian People · Blood Glucose / metabolism · Blood Pressure · Body Mass Index · Body Weight* · Cohort Studies · Diabetes Mellitus, Type 2 / blood / complications / ethnology / physiopathology · Diabetic Retinopathy / blood / complications / ethnology / physiopathology · Female · Glycated Hemoglobin / metabolism · Humans · Life Style · Male · Middle Aged · Obesity / blood / complications / ethnology / physiopathology · Risk Factors
Substances
Blood Glucose · Glycated Hemoglobin · hemoglobin A1c protein, human
연구비
NIDDK NIH HHS K23 DK080228 · NIDDK NIH HHS K23 DK 080228-05
참고문헌
33편